Cryptocurrency expert explores AbCellera Biologics (ABCL) stock potential. With Cramer's prediction of over $100 billion value on FDA approval, investors wonder if ABCL is a 10X return or risky bet. This stock analysis delves into why ABCL stock prices are falling, offering insights for crypto-savvy investors.